The growing number of medical cannabis brands and products available to patients in Germany indicates that companies wanting to enter and succeed in that market need to think beyond simply offering a consistent supply of products.
As competition grows …
Dronabinol
Synthetic cannabinoids linked to increased hospitalizations and deaths in older adults with COPD
A study out of St. Michael’s Hospital in Toronto has found prescription synthetic cannabinoids are linked to a 64-percent increase in death in older patients with chronic obstructive pulmonary disease (COPD). These oral drugs—nabilone and dronabinol—ha…